Merck & Co CEO Meets Prime Minister

BMI View: Thailand's THB127bn (US$3.96bn) pharmaceutical market represents a moderate proposition to multinational pharmaceutical companies. Although projected growth is robust (five-year compound annual growth rate (CAGR) = 3.9%), per-capita spending is relatively low (US$58 in 2010). The regulatory regime is also challenging, especially for foreign firms.

To read the full article, please choose one of the following options: